Abnormal mitochondria in muscle tissue
0.100
Biomarker
disease
HPO
Acidosis, Lactic
0.100
Biomarker
phenotype
HPO
Acquired Kyphoscoliosis
0.100
Biomarker
disease
HPO
Acute GVH disease
0.010
GeneticVariation
disease
BEFREE
The incidences of grades II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were 34 (95% CI 30 -37%) and 51 (95% CI 46-56%), respectively.
29713245
2018
Anemia
0.100
Biomarker
disease
HPO
×
CUI:
C0003578
Disease:
Apnea
Apnea
0.100
Biomarker
phenotype
HPO
Asthenozoospermia
0.010
AlteredExpression
disease
BEFREE
These results suggest that the impaired mitochondrial activity could be due to the broken interaction between DJ-1 and NDUFS3 and that downregulation of DJ-1 in sperm and testes contributes to AS pathogenesis.
29849492
2018
Ataxia
0.100
Biomarker
phenotype
HPO
Blepharoptosis
0.100
Biomarker
disease
HPO
Blindness
0.100
Biomarker
phenotype
HPO
Breast Carcinoma
0.310
Biomarker
disease
BEFREE
We also observed that the expressions of GRIM-19, NDUFS3 , and ECM elements were correlated with invasive capabilities of breast cancer cell lines.
23630608
2013
Breast Carcinoma
0.310
Biomarker
disease
CTD_human
An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells.
21466612
2011
Cardiomegaly
0.200
Biomarker
phenotype
RGD
Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat.
24388463
2014
Chemical and Drug Induced Liver Injury
0.300
Biomarker
disease
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
Chemically-Induced Liver Toxicity
0.300
Biomarker
disease
CTD_human
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
25231249
2015
Coinfection
0.010
Biomarker
phenotype
BEFREE
Of these people, 7326 had T gondii co-infection and we estimated the pooled worldwide prevalence of T gondii infection to be 35·8% (95% CI 30 ·8-40·7).
28159548
2017
Congenital kyphoscoliosis
0.100
Biomarker
disease
HPO
Decreased activity of mitochondrial complex I
0.100
Biomarker
phenotype
HPO
Decreased activity of mitochondrial respiratory chain
0.100
Biomarker
phenotype
HPO
Decreased activity of the pyruvate dehydrogenase complex
0.100
Biomarker
phenotype
HPO
Deglutition Disorders
0.100
Biomarker
group
HPO
Dementia
0.010
GeneticVariation
disease
BEFREE
Median age at onset was 35 years (95% CI 30 -36) for asymptomatic pre-MCI, 38 years (37-40) for symptomatic pre-MCI, 44 years (43-45) for MCI, and 49 years (49-50) for dementia .
21296022
2011
Diabetes Mellitus
0.100
Biomarker
group
HPO
Diabetes Mellitus, Experimental
0.200
Biomarker
disease
RGD
Mitochondrial proteome analysis reveals depression of the Ndufs3 subunit and activity of complex I in diabetic rat brain.
22387129
2012
Diabetes Mellitus, Experimental
0.200
Biomarker
disease
RGD
Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats.
20876714
2011